ABSTRACT: Anabolic implants are routinely used in the finishing phase of beef production to improve animal performance and feed efficiency. Implanting during the feedlot phase on average increases ADG 18%, feed intake 6%, feed efficiency 8%, carcass weight 5%, and ribeye area 4% compared with nonimplanted controls. Implants reduce the cost of beef production, which is important given current high feed costs and beef prices. In a 1996 review of 37 implant trials, the use of a combination (i.e., estrogenic and trenbolone acetate) implant increased returns by US$77/head compared with nonimplanted steers. If calculated using today's prices, a combination implant would increase returns by $163/head. However, concerns about potential negative effects of implants on marbling scores, quality grades, and tenderness exist. Changes in Warner-Bratzler shear force values of steaks from implanted steers are small (<0.5 kg) and appear related to an increase in initial tenderness, possibly due to hypertrophy of muscle fiber, instead of alterations in postmortem proteolysis. The increase in ribeye size observed with implanting may also reduce marbling scores through a dilution effect. The impact of anabolic implants on gene expression has shown that implanting downregulates expression of certain lipogenic genes (e.g., stearoyl-CoA desaturase, fatty acid synthetase, fatty acid elongase-6) in steers with low quality grades (Select-) but not in implanted steers with high quality grades (Choice-). Examination of the adipocyte's transcriptome has shown that 36 genes were differentially expressed due to implant treatment. More research is needed to further determine how anabolic implants alter lipogenic gene expression to address changes in marbling deposition with implant usage. Given our current high feed costs and cattle prices, anabolic implants are one of the most cost-effective technologies that can be used in beef production systems.
INTRODUCTION
Anabolic implants are routinely used in the finishing phase of beef production to improve animal performance and feed efficiency (Preston, 1999; Nichols et al., 2002; Reinhardt, 2007) . According to the National Animal Health Monitoring Survey (NAHMS, 2000) , which surveyed 96% of total feedlot cattle inventory with 1,000 head or more, 97% of all feedlot steers weighing over 318 kg received at least 1 anabolic implant during the finishing period. Of those implanted, only 32% received more than 1 implant during the finishing period. Sixty percent of steers receiving 1 implant during the finishing period contained an androgenic agent whereas 80% of steers receiving 2 or more implants contained an androgenic agent.
Implant products are available for suckling calves, grazing cattle, and finishing cattle. Producers have numerous choices available when using implants to decrease production costs. Currently, 33 implant products are approved for use in beef cattle (FDA, 2013 ; Table 1 ). In a 1996 review of 37 implant trials (Duckett et al., 1996) , the use of a combination (estrogenic and trenbolone acetate) implant increased returns by $77/ head compared to nonimplanted steers. If calculated in today's prices, a combination implant would increase returns by $163/head ( Table 2 ). The use of 2 combination implants during the finishing phase would return an estimated $218.58/head over nonimplanted control. Capper and Hayes (2012) reported that if growth-enhancing technologies (i.e., anabolic implants, ionophores, β-adrenergic agonists, or in-feed hormones) were eliminated in U.S. beef production systems, that feedstuff and land use would have to increase by 2,830 × 10 3 t and 265 × 10 3 ha, respectively, to maintain beef production levels. In addition, there would be an additional 1,799 × 10 3 t of additional manure output and increased carbon emissions without the use of growth promotants. Certainly, the value of anabolic implants in beef production is not under question but concerns over their potential impact on carcass quality grade and palatability have been raised. This review will focus on the impact of anabolic implants on skeletal maturity, marbling deposition, and tenderness.
EffECTS ON PERfORmANCE AND CARCASS TRAITS
Anabolic implants are approved for use in feedlot heifers and steers for increased rate of weight gain and improved feed efficiency (FDA, 2013) . Currently, feed prices and cost of gain are at an all-time high in the beef industry. The use of technology that decreases cost of gain by improving feed efficiency is extremely valuable in these times of high feed costs. The average increases in gain and feed efficiency and carcass traits are shown in Tables 3 and 4 , respectively. These averages are assembled from the implant database constructed by Duckett et al. (1996 Duckett et al. ( , 1997 , updated annually to compare responses across many implant trials to summarize results, and analyzed according to Duckett et al. (1997) . Data were analyzed by GLM procedure of SAS (SAS Inst. Inc., Cary, NC) to test implant type effects and weighted by the number of steers per treatment. Average daily gain was increased (P < 0.05) by 16 to 20% over the nonimplanted control for anabolic implants. Feed efficiency, reported as feed to gain, was reduced (i.e., improved; P < 0.05) by 9 to 14% in implant strategies containing a combination implant compared with nonimplanted controls.
A single estrogenic implant administered during the finishing phase increased hot carcass weight numerically by 3% over nonimplanted controls whereas a single combination or reimplanting during the finishing phase increased (P < 0.05) hot carcass weight by 6 to 7.5% over nonimplanted controls (Table 4) . For combination implants, LM area was increased (P < 0.05) by 5.8 and Duckett et al., 1996) . The effect of implanting on percentage KPH appears to be variable among studies (Duckett et al., 1996 (Duckett et al., , 1997 . Most studies report no change in KPH but some report a reduction in the percentage of KPH likely related to differences in HCW because KPH is expressed as a percentage of HCW. Overall, the increase in HCW with implanting is balanced by the change in LMA such that yield grade number changes only slightly in response to implanting.
Effects on Skeletal Maturity, Marbling, and Tenderness
Skeletal Maturity. Anabolic implants advance skeletal maturity by about 10 points on scale of 100 for each of the 5 degrees of maturity (Duckett et al., 1996) . Roeber et al. (2000) found skeletal maturities similar to nonimplanted controls when the initial combination implant was administered at 59 d after the beginning of the trial compared with implanting at 0 d, which advanced skeletal maturities by 11 or 16 points. Paisley et al. (1999) evaluated the effect of various estrogenic implants (i.e., Synovex-C, Synovex-S [Zoetis, Florham Park, NJ], or Revalor-G [Merck Animal Health, Summitt, NJ]) in steers during wintering period on skeletal maturity. The steers were harvested at about 22 mo of age and skeletal maturity was advanced by 20 to 24% with the use of estrogenic implants during the wintering phase. Reiling and Johnson (2003) reported greater skeletal maturities and ash content in cartilaginous buttons of the top 3 thoracic vertebrae in carcasses of implanted steers than nonimplanted. Skeletal maturity and ash content of cartilaginous buttons were greater in carcasses from steers receiving both initial and reimplant of Revalor-S versus steers implanted with Ralgro (Merck Animal Health, Summit, NJ) initially followed by Revalor-S. Lean maturity was also greater for Revalor-S/Revalor-S than nonimplanted control with Ralgro (Merck Animal Health, Summit, NJ)/Revalor-S intermediate. Scheffler et al. (2003) showed a linear increase in skeletal maturity with number of combination implants used during the finishing period (0 = A 55 , 1 = A 61 , 2 = A 78 , and 3 = A 88 ). Similarly, Platter et al. (2003) reported linear increases in overall maturity with number of implants administered throughout the lifetime of steers (0 = A 57 , 2 = A 55 , 3 = A 58 , 4 = A 62 , and 5 = A 64 ). These authors also noted that use of an implant at branding time advanced overall maturity whereas implants administered at weaning or during backgrounding did not alter overall maturity (Platter et al., 2003) .
Marbling Deposition. The reduction in marbling score observed with implanting is shown in Table 4 . A single estrogenic implant reduced (P < 0.05) marbling score on average -3.75% compared with nonimplanted control whereas reimplanting with estrogenic or combination implants resulted in greater reductions (P < 0.05) in marbling score [estrogenic implant with estrogenic reimplant (E/E) = -7.4% or estrogenic implant with combination reimplant (E/C) = -11.5%] compared with the nonimplanted control. A single combination implant reduced (P < 0.05) marbling score by about -4.6% and 2 combination implants reduced (P < 0.05) marbling score by -9.3% compared with nonimplanted control. These reductions in marbling score correspond to the increases in LM area observed with the various implant types. Duckett and Andrae (2001) have previously shown a negative relationship between marbling score and LM area in implanted cattle (marbling score = -0.796 × percentage increase in LM area -1.99; r 2 = 0.68). Previous research (Duckett et al., 1999) indicates that implanting seems to alter intramuscular lipid amount and composition through a dilution effect with the increase in LM area. Johnson et al. (1996) conducted a serial slaughter study (40, 115, and 143 d on feed) after an initial im- .4* C/C 20.0* -13.5* *Denotes significance (P < 0.05) from nonimplanted control. 1 E = estrogenic; E/E = estrogenic with reimplant of estrogenic; E/C = estrogenic with reimplant of combination; C = combination; C/C = combination with reimplant of combination. See Table 1 for implant type information. C/C 7.46* 9.0* -9.34* *Denotes significance (P < 0.05) from nonimplanted control. 1 E = estrogenic; E/E = estrogenic with reimplant of estrogenic; E/C = estrogenic with reimplant of combination; C = combination; C/C = combination with reimplant of combination. See Table 1 Scheffler et al. (2003) have shown that the timing of implant administration alters marbling score with late administration of a single combination implant reducing marbling score to a greater extent that those administered earlier and throughout the finishing phase (Fig. 1) . Others have shown that reimplanting with a combination implant halfway through the finishing phase results in lower marbling scores than single implant administered at trail initiation (Duckett et al., 1996; Roeber et al., 2000) . Bruns et al. (2005) evaluated a delayed (Revalor-S on d 57) implanting scheme versus an initial (Revalor-S d 0) at the start of the finishing period or nonimplanted control in Angus and AngusLimousin cross steers. The delayed implanting scheme resulted in quality grade distributions similar to nonimplanted control and greater percentage of premium Choice carcasses than those implanted initially (23 vs. 8%). Overall marbling scores were lower for initial implant than nonimplanted control with the delayed implant being intermediate. The effects of implanting on marbling score appear related to timing of implant administration and resultant increases in LM growth. Therefore, implant strategies should be designed to minimize marbling reductions by delaying the initial implant by about 50 to 60 d and avoiding a reimplant.
Longissimus muscle area and intramuscular fat content are altered by implants; it is reasonable to assume that these changes occur via alterations in cell function through changes in gene expression. Research shows that anabolic compounds do not alter in vitro lipolysis rates of adipocytes from ewes (Green et al., 1992) or steady state mRNA concentrations of lipoprotein lipase (a lipogenic enzyme that catalyzes the uptake of fatty acids from serum to tissues) in LM biopsies taken from Revalor-S implanted steers (Waylan et al., 2004) . In addition, combination implants (i.e., Synovex-plus at initiation and midpoint of finishing) did not alter subcutaneous or intramuscular adipocyte size or volume or mRNA levels of key lipogenic enzymes (i.e., acetyl-CoA carboxylase, stearoyl-CoA desaturase, or lipoprotein lipase) in intramuscular fat (Smith et al., 2007) . More recent research has shown that implanting downregulates certain lipogenic (i.e., stearoyl-CoA desaturase, fatty acid synthase, and fatty acid elongase 6) genes in steers with low quality grades (Select-) but not in implanted steers with higher quality grades (Choice-; Duckett et al., 2011) . Examination of the adipocyte transcriptome has shown that 36 genes were differentially expressed due to implant treatment (Duckett et al., 2012) ; in contrast, over 95 genes were differentially expressed due to adipose depot location (i.e., subcutaneous vs. mesenteric). Interestingly, the genes differentially expressed in the transcriptome were not lipogenic genes; instead the genes were related to insulin resistance, cell cycle regulation, and adipogenic differentiation. Adipocyte gene expression is impacted by both location and implant treatment, which indicates that strategies could be developed to adjust lipid accumulation based on location and exogenous hormonal treatment. Marbling deposition proceeds in a nonlinear manner such that most deposition typically occurs when lean growth has plateaued (Duckett et al., 1993 ) and excess energy is available for deposition by adipocytes. Therefore, implant schemes that stimulate lean growth in the middle to end of the finishing period appear to have the greatest influence on marbling scores, possibly by limiting the available energy for marbling deposition. If anabolic implants do not exert a direct effect on lipolysis or lipogenesis, then altering management to avoid reimplanting during the period of enhanced marbling deposition (i.e., d 84 to 112 time-on-feed during finishing phase; Duckett et al., 1993) could potentially reduce the negative effects of implants on marbling score and percent grading Choice.
Tenderness. Results from implant studies to evaluate the effects of implanting on LM Warner-Bratzler shear force (WBSf), trained sensory panels, and/or consumer sensory panels have been variable between studies (Table 5) . Gerken et al. (1995) reported increased WBSF values in steaks from steers implanted with Synovex-S (+14.5%) and Revalor-S (+16.78%) compared with nonimplanted controls or Finaplix-S (Merck Animal Health, Summit, NJ). Milton et al. (1996) reported no change in WBSF values from implanting with C (combination implant) or E (estrogenic implant) in various implanting schemes. Samber et al. (1996) found higher WBSF values in steaks from steers implanted twice or 3 times with Revalor-S compared with nonimplanted controls or those implanted with an estrogenic implant initially (Ralgro/Synovex-S/ Revalor-S, Ralgro/Revalor-S/Revalor-S, or Synovex-S/ Revalor-S). Roeber et al. (2000) reported numerically higher (tougher) WBSF values but higher (more tender) consumer sensory level of tenderness ratings for implanted versus nonimplanted. The magnitude of the difference in shear force values and sensory tenderness ratings were small (i.e., 0.4 kg shear force and 0.5 point on a 9 point scale, respectively) and the overall like to dislike rating was similar between implant and nonimplant treatments. Barham et al. (2003) evaluated 3 implant treatments [1) nonimplanted control, 2) Synovex-S on d 0 and 80 to 90, and 3) Synovex-S on d 0 and Revalor-S on d 80 to 90] on shear force, trained sensory evaluation, and consumer evaluations. Warner-Bratzler shear force values were similar among implant treatments; however, trained sensory panelists rated initial and sustained tenderness higher and more desirable for nonimplanted controls than either implant treatments. No differences were detected in trained sensory panel ratings for juiciness, beef flavor, flavor intensity, and overall mouth feel between implant treatments. Consumer panel evaluation scores of overall acceptability, tenderness acceptability, overall quality, flavor, juiciness, and tenderness were similar between steaks from implanted steers and nonimplanted controls. Numerical increases in overall and tenderness acceptability, indicating increased unacceptability, were noted for steaks from steers implanted with Synovex-S followed by Revalor-S compared with Synovex-S implanted on d 0 and 84 or nonimplanted controls. Kerth et al. (2003) reported reduced WBSF values in LM from heifers implanted with Revalor-S on d 0 and 84 compared with nonimplanted controls. Comparisons among other implant treatments were nonsignificant. Trained sensory analysis of initial juiciness, initial tenderness, sustained tenderness, flavor intensity, beef flavor, or overall mouth feel were unaffected by implant treatment. Sustained juiciness scores were higher, more desirable, for steaks from heifers implanted once with Revalor-H at d 84 versus those implanted at d 0 and 84 with Revalor-H. Igo et al. (2011) reported no change in WBSF values for Revalor-IS with reimplant of Revalor-S or a single Revalor-S implant compared with nonimplanted controls for Choice or Select strip steaks aged for 14 or 21 d postmortem. Consumer panel evaluations showed no differences in overall acceptability or tenderness acceptability for Choice strip steaks; however, consumers rated overall acceptability lower for implanted Select strip steaks when aged for 14 d. Aging to 21 d improved consumer acceptability of implanted Select strip steaks to the levels of nonimplanted controls. These results show that extended 1 A = androgenic, C = combination, E = estrogenic, E/E = estrogenic implant and reimplant, E/C = estrogenic implant with combination reimplant, C/C = combination implant and reimplant, E/C/C = estrogenic implant with 2 combination reimplants, C/C/C = 3 combination implants, N/C = no implant initially followed by combination implant.
aging (21 d) can diminish differences in consumer acceptability of implanted steaks with lower quality grades (i.e., Select). Scheffler et al. (2003) (Fig.  2) . Platter et al. (2003) also showed a similar response between number of implants and shear force values (Fig. 3) . Shear force values increased with administration of 1 to 3 more implants and then shear force leveled off when more than 3 implants were administered in a lifetime implant scheme. In our laboratories (Smith et al., 2007) , shear force values for steaks from implanted (Synovex-plus/Synovex-plus) steers were higher than nonimplanted controls at d 1, 3, and 7 d of postmortem aging. (Fig. 4) The interaction between implant treatment and postmortem aging time was nonsignificant, indicating that the rate of postmortem aging was not altered with implanting. Similarly, Gerken et al. (1995) and Barham et al. (2003) also evaluated postmortem aging time and implanting, and both reported interactions between aging time and implant treatment to be nonsignificant. These results indicate that the response to WBSF with implanting may be related to increases in myofibrillar diameter as a result of increased muscle hypertrophy with implanting. Increases in myofibrillar diameter would likely increase shear force and account for the higher shear force values observed at initial postmortem ages. Additional research is needed to ascertain the true effect of implanting on tenderness to determine if increases in myofibrillar size and/ or proteolytic enzyme activity are responsible for the changes observed.
SUmmARY AND CONCLUSIONS
Anabolic implants are one of the most cost-effective technologies that can be used in beef cattle finishing systems. Concerns over the use of implants in finishing cattle are related to changes in skeletal maturity, marbling scores, and tenderness. Using more than 2 implants in the finishing period can increase skeletal maturity and WBSF and reduce marbling scores. Timing of implant administration appears critical to minimize negative impacts on marbling deposition. Additional research is needed to gain a better understanding of how anabolic implants directly impact adipogenesis and postmortem proteolysis to develop management systems that best use anabolic implants to enhance growth without negative effects on marbling and tenderness. figure 2. Change in Warner-Bratzler shear force (WBS; kg) and LM area (LMA; cm 2 ) with number of implants compared to nonimplanted controls (Scheffler et al., 2003) . 
